Access to Drug Treatments
This page has the latest updates about the impact of COVID-19 on access to drug treatments, clinical trials and regulatory authority timetables. For other information on research and drug treatments, please go here. You may find it helpful to watch our webinars about virtual assessments and coming to clinic, here.
Expert clinicians advised (01/05/2020) that they are not asking for patients to be tested before attending for nusinersen treatment, but if unwell (even if not COVID-19 positive) and even more so if COVID-19 positive, they would generally advise to postpone treatment. This may vary – talk with your treatment team if you’re not sure about what’s happening at your centre.